Proscia: Revolutionizing Pathology in the Digital Age
Proscia is at the forefront of transforming the field of pathology with its advanced enterprise pathology platform, Concentriq. This platform is a game-changer for both anatomic pathology laboratories and life sciences organizations.
In the Overview section, it's clear that Concentriq serves as a bridge, connecting these two crucial sectors. It enables the use of real-world pathology data to fuel innovation and improve patient care. This is a significant step forward in the world of digital pathology.
The Core Features of Concentriq are impressive. It allows for 100% digitization in anatomic pathology laboratories, leading to faster and more precise results. Additionally, it drives efficiency and insight across the drug R&D value chain, from discovery to development.
When it comes to Basic Usage, Concentriq delivers an open platform that acts as a hub for running a variety of AI applications. This includes Proscia's own algorithms as well as those from a broad partner portfolio.
Proscia is not only recognized for its innovative solutions but also for the trust it delivers. The 2024 KLAS Emerging Company Spotlight acknowledges Concentriq as a digital pathology software that overcomes diagnostic challenges and boosts lab efficiency.
With events like the Digital Pathology and AI Congress EU (DPAIC) and webinars on unlocking the promise of foundation models, Proscia is actively contributing to the advancement of pathology and AI in this field.
